Galectin Therapeutics (GALT) Reports the Positive Outcome of the Fourth Data and Safety Monitoring Board Meeting for NAVIGATE streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
StockNews.com began coverage on shares of Galectin Therapeutics (NASDAQ:GALT – Free Report) in a report issued on Thursday. The firm issued a hold rating on the stock. Separately, HC Wainwright reiterated a buy rating and issued a $11.00 target price on shares of Galectin Therapeutics in a research note on Tuesday, August 15th. Get Our […]
StockNews.com initiated coverage on shares of Galectin Therapeutics (NASDAQ:GALT – Free Report) in a research note released on Wednesday morning. The firm issued a hold rating on the stock. Separately, HC Wainwright restated a buy rating and set a $11.00 price objective on shares of Galectin Therapeutics in a research report on Tuesday, August 15th. […]
/PRNewswire/ According to a comprehensive research report by Brandessence Market Research (BMRC), "Kidney Function Test Market Size, Share Outlook Growth By.
StockNews com Initiates Coverage on Galectin Therapeutics (NASDAQ:GALT) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.